SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline UVV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher NXT Q1 2026 Earnings EPS Surprises 1316 Above Estimates Evaxion Q1 2026 Earnings EPS Miss Weighs on PreRevenue Biotech Stock Edges Higher American Assets Trust AAT Q1 2026 Earnings EPS Miss of 28 but Shares Edge Higher